Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers

Cell Death and Differentiation

Volumn 5, Issue 1, 1998, Pages 107-115

  Brunet, Clare L ^a   Gunby, Rosalind H ^a   Benson, Roderick S P ^a   Hickman, John A ^a   Watson, Alastair J M ^a   Brady, Gerard ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Apoptosis; BCL 2; Caspases; Cell death; Clonogenic

Indexed keywords

CASPASE; DEXAMETHASONE; PROTEIN BCL 2; PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CELL DEATH; CELL MEMBRANE POTENTIAL; CELL STRUCTURE; CHROMATIN CONDENSATION; CLONOGENESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KINETICS; LYMPHOBLASTOID CELL LINE; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0031872523     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400334     Document Type: Article

References (43)

1. Alnemn ES, Lvingston DJ, Nicholson DW, Salvessen G, Thornberry NA, Wong WW and Yuan J (1996) Human ICE/CED-3 protease nomenclature. Cell 87:171
2. An S and Knox KA (1996) Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP. FEBS Lett. 386: 115-122
3. Benson RSP, Heer S, Dive C and Watson AJM (1996) Characterization of cell volume loss in CEM-C7A cells during dexamethasone-induced apoptosis. Am. J. Physiol. 270: 1190-1203
4. Cohen JJ (1993) Apoptosis. Immunol Today 14: 126-130
5. Cossarizza A, Baccarani-Contri M, Kalashnikova G and Franceschi C (1993) A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′- tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun 197: 40-45
6. Cosulich SC, Green S and Clarke PR (1996) Bcl-2 regulates activation of apoptotic proteases in a cell-free system Curr Biol 6: 997-1005
7. Enari M, Hug H and Nagata S (1995) Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375: 78-81
8. Fernandes-Alnemri T, Litwack G and Alnemri ES (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta- converting enzyme. J. Biol. Chem. 269: 30761-30764
9. Fernandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Fritz L, Tomaselli KJ, Wang L, Yu Z, Croce CM, Salveson G, Earnshaw WC, Litwack G and Alnemn ES (1995) Mch3, a novel human apoptotic cysteine protease highly related to CPP32 Cancer Res 55: 6045-6052
10. Furth EE, Thilly WG, Penman BW, Liber HL and Rand WM (1981) Quantitative assay for mutation in diploid human lymphoblasts using microtitre plates. Anal. Biochem. 110: 1-8
11. Geley S, Hartmann BL, Kapelari K, Egle A, Villunger A, Heidacher D, Greil R, Auer B and Kofler R (1997a) The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells. FEBS Lett. 402: 36-40
12. Geley S, Hartmann BL and Kofler R (1997b) Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl-2, but not by CrmA. FEBS Lett 400: 15-18
13. Hashimoto H, Chatterjee S and Berger NA (1995) Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bci-2 protein over-expression. Cancer Res. 55: 4029-4035
14. Helmberg A, Auphan N, Caelles C and Karin M (1995) Glucocorticoid-induced apoptosis of human leukemic cells is caused by therepressive function of the glucocorticoid receptor. EMBO J. 14: 452-460
15. Jacobsen MD, Weil M and Raff MC (1996) Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J Cell Biol. 133: 1041-1051
16. Kamesaki S, Kamesaki H, Jorgensen TJ, Tanizawa A, Pommier Y and Cassman J (1993) bcl-2 protein inhibits chemotherapy induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res 53: 4251-4256
17. Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for BCL-2 regulation of apoptosis Science 275: 1132-1136
18. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS and Flavell RA (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267: 2000-2003
19. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, Rakic P and Flavell RA (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368-372
20. Lazebnik YA, Kaufman SH, Desnoyers S, Poirier GG and Eamshaw WC (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347
21. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J, Towne E, Tracey D, Wardwell S, Wei FY, Wong W, Kamen R and Seshadn T (1995) Mice deficient in il-1-beta-converting enzyme are defective in production of mature il-1-beta and resistant to endotoxic-shock Cell 80 401-411
22. Lock RB and Stribinskiene L (1996) Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res. 56: 4006-4012
23. Longthorne VL and Williams GT (1997) Caspase activity is required for commitment to fas-mediated apoptosis. EMBO J. 16: 101-109
24. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerie PA, Droege W, Krammer PH, Fiers W and Schulze-Osthof K (1995) Requirement of an ICE/CED-3 protease for Fas/APO-1 mediated apoptosis. Nature 375: 81-83
25. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM and Green DR (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182: 1545-1556
26. McCarthy NJ, Whyte MKB, Gilbert CS and Evan GI (1997) Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes. DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol 136: 215-227
27. Miyashita TUM, Inoue T, Reed JC and Yamada M (1997) Bcl-2 relieves the transrepressive function of the glucocorticoid receptor and inhibits the activation of CPP32-like cysteine proteases. Biochem. Biophys. Res Commun. 233: 781-787
28. Nicholson DW, All A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL and Miller DK (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Nature 376 37-43
29. Norman MR and Thompson EB (1977) Characterization of a glucocorticoid-sensitive human lymphoid cell line. Cancer Res. 37: 3785-3791
30. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR and Sikorska M (1993) Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12: 3679-3684
31. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin TT and Nicholson DW (1996) CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis J. Biol. Chem. 271: 1841-1844
32. Shaham S and Horvitz HR (1996) Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities Genes Dev. 10: 578-591
33. Strasser A, Harris AW, Jacks T and Cory S (1994) DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2 Cell 79: 329-339
34. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M and KroemerG (1996) Bcl-2 inhibits the mitochondria release of an apoptogenic protease J Exp. Med. 184: 1331-1341
35. Walker A, Taylor ST, Hickman JA and Dive C (1997) Germinal centre-derived signals act with BCL-2 to decrease apoptosis and increase clonogenicity of drug-treated human B-lymphoma cells. Cancer Res. 57: in press
36. Wood AC, Waters CM, Garner A and Hickman JA (1994) Changes in c-myc expression and the kinetics of dexamethasone-induced programmed cell death (apoptosis) in human lymphoid leukaemia cells Br. J. Cancer 69: 663-669
37. Wyllie AH, Kerr JFR and Currie AR (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68: 251-306
38. Xiang J, Chao DT and Korsmeyer SJ (1996) BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases Proc. Natl. Acad. Sci. U.S.A. 93: 14559-14563
39. Yang E and Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88: 386-401
40. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP and Wang X (1997) Prevention of apoptosis by BCL-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132
41. Yin DX and Schimke RT (1995) Bcl-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res 55: 4922-4928
42. Yuh YS and Thompson EB (1989) Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone. J. Biol. Chem. 264: 10904-10910
43. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX and Kroemer G (1995) Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181: 1661-1672